JB Capital LLC Has $2.71 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

JB Capital LLC reduced its holdings in CVS Health Co. (NYSE:CVS) by 30.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,288 shares of the pharmacy operator’s stock after selling 15,132 shares during the period. JB Capital LLC’s holdings in CVS Health were worth $2,708,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its position in CVS Health by 0.4% during the third quarter. Vanguard Group Inc. now owns 117,162,626 shares of the pharmacy operator’s stock valued at $8,180,295,000 after purchasing an additional 485,744 shares in the last quarter. State Street Corp increased its stake in shares of CVS Health by 1.6% in the second quarter. State Street Corp now owns 55,877,387 shares of the pharmacy operator’s stock worth $3,862,804,000 after acquiring an additional 855,269 shares during the last quarter. Morgan Stanley boosted its position in CVS Health by 10.9% during the fourth quarter. Morgan Stanley now owns 33,576,388 shares of the pharmacy operator’s stock valued at $3,128,984,000 after purchasing an additional 3,311,928 shares during the last quarter. FMR LLC increased its position in CVS Health by 29.1% in the 3rd quarter. FMR LLC now owns 27,487,238 shares of the pharmacy operator’s stock worth $1,919,159,000 after purchasing an additional 6,194,441 shares during the last quarter. Finally, Moneta Group Investment Advisors LLC raised its stake in shares of CVS Health by 103,371.0% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,547,559 shares of the pharmacy operator’s stock worth $1,448,877,000 after purchasing an additional 15,532,533 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $76.95, for a total value of $2,267,947.35. Following the sale, the executive vice president now directly owns 39,765 shares in the company, valued at approximately $3,059,916.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.25% of the company’s stock.

CVS Health Trading Down 0.2 %

CVS stock traded down $0.19 during midday trading on Monday, reaching $79.57. The stock had a trading volume of 762,297 shares, compared to its average volume of 11,124,455. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25. The firm has a market cap of $100.13 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.05 and a beta of 0.52. The business has a fifty day simple moving average of $75.91 and a two-hundred day simple moving average of $73.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same period in the previous year, the firm posted $1.99 earnings per share. CVS Health’s revenue for the quarter was up 11.9% compared to the same quarter last year. As a group, research analysts expect that CVS Health Co. will post 8.33 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a yield of 3.34%. CVS Health’s dividend payout ratio is presently 41.18%.

Wall Street Analyst Weigh In

CVS has been the subject of a number of analyst reports. Royal Bank of Canada reduced their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. StockNews.com downgraded CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Leerink Partnrs reiterated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. HSBC started coverage on shares of CVS Health in a research report on Friday, December 22nd. They set a “buy” rating and a $94.00 target price on the stock. Finally, TD Cowen decreased their price target on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating on the stock in a research report on Monday, December 11th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.